127 related articles for article (PubMed ID: 16424109)
21. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes.
Zhang T; He J; Xu C; Zu L; Jiang H; Pu S; Guo X; Xu G
J Mol Endocrinol; 2009 Jan; 42(1):57-66. PubMed ID: 18955435
[TBL] [Abstract][Full Text] [Related]
23. Novel mechanisms of the regulation of protein kinase B in adipocytes; implications for protein kinase A, Epac, phosphodiesterases 3 and 4.
Zmuda-Trzebiatowska E; Manganiello V; Degerman E
Cell Signal; 2007 Jan; 19(1):81-6. PubMed ID: 16839743
[TBL] [Abstract][Full Text] [Related]
24. Differential function of the alpha2A-adrenoceptor and Phosphodiesterase-3B in human adipocytes of different origin.
Dicker A; Kaaman M; van Harmelen V; Aström G; Blanc KL; Rydén M
Int J Obes (Lond); 2005 Dec; 29(12):1413-21. PubMed ID: 16077714
[TBL] [Abstract][Full Text] [Related]
25. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.
He J; Xu C; Kuang J; Liu Q; Jiang H; Mo L; Geng B; Xu G
Metabolism; 2015 Jul; 64(7):826-36. PubMed ID: 25825274
[TBL] [Abstract][Full Text] [Related]
26. Dimethylaminopurine inhibits metabolic effects of insulin in primary adipocytes.
Göransson O; Rydén M; Nilsson R; Arner P; Degerman E
J Nutr Biochem; 2004 May; 15(5):303-12. PubMed ID: 15135155
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of lipolysis by palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets.
Müller G; Wied S; Over S; Frick W
Biochemistry; 2008 Feb; 47(5):1259-73. PubMed ID: 18186616
[TBL] [Abstract][Full Text] [Related]
28. Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulin- and cAMP-dependent activation by phosphorylation.
Smith CJ; Vasta V; Degerman E; Belfrage P; Manganiello VC
J Biol Chem; 1991 Jul; 266(20):13385-90. PubMed ID: 1649189
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid.
Matousovic K; Tsuboi Y; Walker H; Grande JP; Dousa TP
J Lab Clin Med; 1997 Nov; 130(5):487-95. PubMed ID: 9390636
[TBL] [Abstract][Full Text] [Related]
30. No in vitro effects of fatty acids on glucose uptake, lipolysis or insulin signaling in rat adipocytes.
Lundgren M; Eriksson JW
Horm Metab Res; 2004 Apr; 36(4):203-9. PubMed ID: 15114517
[TBL] [Abstract][Full Text] [Related]
31. Genistein, a plant-derived isoflavone, counteracts the antilipolytic action of insulin in isolated rat adipocytes.
Szkudelska K; Nogowski L; Szkudelski T
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):108-14. PubMed ID: 18207734
[TBL] [Abstract][Full Text] [Related]
32. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes.
Zhou L; Wang X; Yang Y; Wu L; Li F; Zhang R; Yuan G; Wang N; Chen M; Ning G
Biochim Biophys Acta; 2011 Apr; 1812(4):527-35. PubMed ID: 20969954
[TBL] [Abstract][Full Text] [Related]
33. In vivo effects of phosphodiesterase III inhibitors on glucose metabolism and insulin sensitivity.
Yang G; Li L
J Chin Med Assoc; 2003 Apr; 66(4):210-6. PubMed ID: 12854872
[TBL] [Abstract][Full Text] [Related]
34. Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion.
Cheung P; Yang G; Boden G
Metabolism; 2003 Nov; 52(11):1496-500. PubMed ID: 14624413
[TBL] [Abstract][Full Text] [Related]
35. Antilipolytic actions of vanadate and insulin in rat adipocytes mediated by distinctly different mechanisms.
Li J; Elberg G; Sekar N; bin He Z; Shechter Y
Endocrinology; 1997 Jun; 138(6):2274-9. PubMed ID: 9165011
[TBL] [Abstract][Full Text] [Related]
36. Identification of the insulin-regulated interaction of phosphodiesterase 3B with 14-3-3 beta protein.
Onuma H; Osawa H; Yamada K; Ogura T; Tanabe F; Granner DK; Makino H
Diabetes; 2002 Dec; 51(12):3362-7. PubMed ID: 12453887
[TBL] [Abstract][Full Text] [Related]
37. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
Chini CC; Grande JP; Chini EN; Dousa TP
J Biol Chem; 1997 Apr; 272(15):9854-9. PubMed ID: 9092521
[TBL] [Abstract][Full Text] [Related]
38. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.
Zierath JR; Livingston JN; Thörne A; Bolinder J; Reynisdottir S; Lönnqvist F; Arner P
Diabetologia; 1998 Nov; 41(11):1343-54. PubMed ID: 9833943
[TBL] [Abstract][Full Text] [Related]
39. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase.
Lönnroth P; Smith U
Biochem Biophys Res Commun; 1986 Dec; 141(3):1157-61. PubMed ID: 2434081
[TBL] [Abstract][Full Text] [Related]
40. PDE3 and PDE4 isozyme-selective inhibitors are both required for synergistic activation of brown adipose tissue.
Kraynik SM; Miyaoka RS; Beavo JA
Mol Pharmacol; 2013 Jun; 83(6):1155-65. PubMed ID: 23493317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
